loading

Moleculin Biotech Inc Stock (MBRX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
25.14%
6.677
8.919 5.947 6.411 8.354
Operating Income/Loss
25.14%
-6.677
-8.919 -5.947 -6.411 -8.354
Income/Loss From Continuing Operations Before Tax
51.60%
-4.97
-10.27 -5.609 -5.976 -7.915
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
51.60%
-4.97
-10.27 -5.609 -5.976 -7.915
Net Income/Loss
51.60%
-4.97
-10.27 -5.609 -5.976 -7.915
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
108.99%
2.4662
-27.44 29.81 29.69 28.75
Basic Earnings Per Share
85.98%
-2.02
-14.41 -0.19 -0.20 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.31
price down icon 0.06%
$84.31
price up icon 0.97%
$364.24
price down icon 0.66%
$23.40
price up icon 0.91%
biotechnology ONC
$256.71
price up icon 4.90%
$118.03
price up icon 0.16%
Cap:     |  Volume (24h):